HOME Top Market Reports Cell-based Assays Market by Product [Reagents & Assay Kits (Cytotoxicity, GPCR), Cell lines, Plate Readers, HCS, HTS, Software & Assay Development Services], Application (Drug Discovery, ADMET), End-user (Pharmaceutical, CRO) - Global Forecast to 2018

Cell-based Assays Market by Product [Reagents & Assay Kits (Cytotoxicity, GPCR), Cell lines, Plate Readers, HCS, HTS, Software & Assay Development Services], Application (Drug Discovery, ADMET), End-user (Pharmaceutical, CRO) - Global Forecast to 2018

By: marketsandmarkets.com
Publishing Date: May 2014
Report Code: BT 2486

 

  Speak to Analyst Enquiry Before Buying
 
purchase report
download pdf  request for customisation


The cell-based assays market is rapidly evolving with a large number of developments taking place to increase accuracy and speed, and reduce costs of drug. The global cell-based assays market is growing at a CAGR of 11.1% from 2013 to 2018 and poised to reach $14.8 billion by 2018. The global cell based assay market is segmented on the basis of products, applications, end users and geography.

The cell-based assays market will witness a double-digit growth attributed to the increase in range of applications. Advantages over biochemical assays and animal models, government initiatives and public-private partnerships, and rising number of drug discovery practices are significant factors propelling the market in the forecast period. On the other hand, high cost of instruments, and maintenance of cell lines are the factors that hinder the market.

Technological advances in stem cell research, newer technologies such as 3D cell based assays, single-cell assays, and advanced detection technologies such as label free detection present numerous growth opportunities for this market. Moreover, the market, dominated by pharmaceutical and biotechnology companies, is witnessing a gradual increase in the market share by government bodies like NIH (National Institute of Health, U.S.) and academic institutions are also increasing the adoption of cell-based assay platforms.

Geographic analysis reveals that U.S. was the largest contributor to the global cell-based assay in 2013. The Asian market however will be the fastest growing region till 2018. The driving factors for the Asian market are the region’s attractiveness for drug discovery outsourcing, rising investments in life science research and technological advancements.
The key players in the cell-based assays market include BD Biosciences (U.S.), Danaher Corporation (U.S.), DiscoveRx (U.S.), EMD Millipore (Germany), GE Healthcare (U.K.), Life Technologies Corporation (U.S.), Perkin Elmer (U.S.), and Promega Corporation (U.S.).

Scope of the Report

Both, product and service markets are in the scope of this report. However, the report does not cover assay volumes market.


Particulars

Scope

Geography

  • North America
  • Europe
  • Asia
  • RoW (Latin America, Middle East, Africa)

Historical Years

2011–2012

Base Year

2013

Forecast Period

2014–2018

Revenue Currency

USD ($)

The global cell-based assays market has been segmented according to the products, types, applications, and end users. Each market is comprehensively analyzed by geography (North America, Europe, Asia, and Rest of the World) to provide in-depth information on the global scenario.

By Product:

  • Cell-Based Assays Consumables
    • Reagents and assay kits
      • Cell Growth Assays
      • Cell Death Assays
      • Second Messenger Assays
      • Reporter Gene Assays
      • Other Assays
        • Microplates
        • Cell- lines
          • Primary Cell Lines
          • Immortalized Cell Lines
          • Stem Cell Lines
        • Other Consumables
    • Instruments
      • Screening Instruments
      • Microplate Readers
      • Fluorescent Microscope
      • High Content Screening
      • Label-Free Detection Instruments
      • Other Instruments
    • Automation Instruments
    • Software
    • Services

By Application:

  • Cell-Based Assay Instruments
    • Cell Imaging and Analysis HCS Systems
    • Flow Cytometers
  • Cell-Based Assay Consumables
    • Reagents and Assay Kits
  • Microplates
  • Other Consumables
  • Cell Based Assay Software
  • Cell Based Assay Services

By Application:

  • Basic Research
  • Drug Discovery
  • ADME Studies
  • Predictive Toxicology
  • Other Applications

By End User:

  • Academic and Government Institutes
  • Pharmaceutical and Biotechnology Companies
  • Contract Research Organizations (CROs)
  • Other End Users

Customization Options

Country Level Market Data

  • North America (U.S. and Canada)
  • Europe (U.K., Germany, France, Italy, Spain and Rest of Europe)
  • Asia (Japan, China, India, and Rest of Asia)
  • Rest of the World (Latin America, Middle East, Pacific countries and Africa)

Market by Volume

Volume market of microplates and detection and screening instruments for cell-based assays including:
  • Microplate Readers
  • Flow Cytometers
  • Label-free Detection Instruments
  • Fluorescent Microscopes
  • High Content Screening Instruments

Product Analysis

  • Product Matrix which gives a detailed comparison of product portfolio of top five companiesfor each segment (consumables, instruments and services)

Cell-based assays market – Regional market share analysis by key players

  • North America
  • Europe
  • Asia

Additional 5 companies can be profiled apart from those profiled in the report

Table Of Contents
 
1 Introduction (Page No. - 19)
    1.1 Objectives of the Study
    1.2 Report Description
    1.3 Markets Covered
    1.4 Stakeholders
    1.5 Market Scope
    1.6 Research Methodology
          1.6.1 Market Size Estimation
    1.6.2 Market Crackdown & Data Triangulation
    1.6.3 Key Data From Secondary Sources
    1.6.4 Key Data Points From Primary Sources
    1.6.5 Assumptions

2 Executive Summary (Page No. - 32)

3 Premium Insights (Page No. - 36)
    3.1 Global Cell-Based Assays Market
    3.2 Market Dynamics
    3.3 Snapshot of the Market
    3.4 Consumables & Instruments Market
    3.5 Geographic Analysis
    3.6 Application Market
    3.7 End User Market

4 Market Overview (Page No. - 43)
    4.1 Introduction
    4.2 Market Dynamics
    4.2.1 Drivers
            4.2.1.1 Significant Advantages of Cell-Based Assays Over Conventional Techniques Provide Ideal Solution For A Range of Research & Commercial Applications
            4.2.1.2 Government Funding and Public-Private Partnerships Support Cell-Based Research Activities
            4.2.1.3 Drug Discovery, Major Driver For Cell-Based Assays Market
            4.2.1.4 Implementation of Hts and Automation Techniques Accelerates the Drug Discovery Process
    4.2.2 Restraints
            4.2.2.1 Shortage of Skilled Experts & High Instrument Costs Have A Negative Impact
            4.2.2.2 Skepticism About Long-Term Benefits of Reporter Assay Kits May Affect their Adoption
            4.2.2.3 Intellectual Property Rights Issues Restrict Innovations in the Market
    4.2.3 Opportunities
            4.2.3.1 Asian Market Presents High-Growth Opportunities
            4.2.3.2 Need to De-Risk Early-Phase Drug Discovery Reinforces Cell-Based toxicity Screening
            4.2.3.3 Developments in High-Content Screening and Software to Transform Cell-Based Screening
    4.2.4 Trends
            4.2.4.1 Use of Stem Cells & 3d Culture Defines the Future of the Market
            4.2.4.2 Assay Development and Assay Screening Services Are the Most Prominent Trend
            4.2.4.3 Label-Free Technologies Are Set to Transform the Market
    4.3 Burning Issues & Challenges
    4.3.1 Consistent Supply of Cells Creates A Bottleneck
    4.3.2 New Technologies Call For Assay Optimization
    4.4 Winning Imperatives
    4.4.1 Assay Multiplexing
    4.4.2 Assay Miniaturization & Microfluidics
    4.5 Porter’s Five Forces Analysis
    4.5.1 Threat From New Entrants
    4.5.2 Threat From Substitutes
    4.5.3 Competitors Rivalry
    4.5.4 Bargaining Power of Suppliers
    4.5.5 Bargaining Power of Buyers
    4.6 Market Share Analysis

5 Cell-Based Assays Market, By Product (Page No. - 63)
    5.1 Introduction
    5.2 Consumables
    5.2.1 Reagents & Assay Kits
            5.2.1.1 Cell Growth Assays
            5.2.1.2 Cell Death Assays
            5.2.1.3 Second Messenger Assays
            5.2.1.4 Reporter Gene Assays
            5.2.1.5 Other Assays
    5.2.2 Microplates
    5.2.3 Cell Lines
            5.2.3.1 Immortalized Cell Lines
            5.2.3.2 Primary Cell Lines
            5.2.3.3 Stem Cell Lines
    5.2.4 Other Consumables
    5.3 Instruments
    5.3.1 Detection & Screening Instruments
            5.3.1.1 Microplate Readers
            5.3.1.2 Flow Cytometers
            5.3.1.3 Fluorescent Microscopes
            5.3.1.4 High Content Screening Instruments
            5.3.1.5 Label-Free Detection Instruments
            5.3.1.6 Other Detection and Screening Instruments
    5.3.2 Automation & High Throughput Screening Instruments
    5.4 Software
    5.5 Services

6 Cell-Based Assays Market, By Application (Page No. - 109)
    6.1 Introduction
    6.2 Basic Research
    6.3 Drug Discovery
    6.3.1 Target Identification and Validation
    6.3.2 Lead Identification & Optimization
    6.4 Absorption, Distribution, Metabolism & Excretion (Adme) Studies
    6.5 Predictive Toxicology
    6.6 Other Applications

7 Cell-Based Assays Market, By End User (Page No. - 126)
    7.1 Introduction
    7.2 Pharmaceutical & Biotechnology Companies
    7.3 Academic & Government Institutions
    7.4 Contract Research Organizations (CRO)
    7.5 Other End Users (Hospitals/Clinical Labs, Food/ Agriculture Industries & Environmental Labs)

8 Cell-Based Assays, By Geography (Page No. - 136)
    8.1 Introduction
    8.2 North America
    8.2.1 Emphasis on Technological Advancements Drives the U.S. Market
    8.2.2 Research Networks in Canada to Boost the Market
    8.3 Europe
    8.3.1 Decline in Venture Capitalist Investments in Early Drug Discovery Shifts the Burden to Public Funding
    8.3.2 Public-Private Partnerships to Accelerate Drug Discovery Process in European Union
    8.4 Asia
    8.4.1 Stem Cell Research in Japan
    8.4.2 Drug Discovery Outsourcing Fuels the Market Growth in China and India
    8.5 ROW

9 Competitive Landscape (Page No. - 179)
    9.1 Introduction
    9.2 New Product Launch
    9.3 Agreements, Collaborations & Partnerships
    9.4 Acquisitions
    9.5 Others

10 Company Profiles (Page No. - 188)
    10.1 Becton, Dickinson and Company
    10.2 Cell Signaling Technology
    10.3 Cisbio Bioassays (Argos Soditic)
    10.4 Danaher Corporation
    10.5 Discoverx
    10.6 EMD Millipore (A Subsidiary of Merck Kgaa)
    10.7 Ge Healthcare (Subsidiary of General Electric Company)
    10.8 Life Technologies (Thermo Fisher Scientific)
    10.9 Perkinelmer, Inc.
    10.10 Promega Corporation
 
*Details on Business Overview, Financials, Product & Services, Key Strategy, & Recent Developments Might Not Be Captured in Case of Unlisted Companies.


List of Tables (88 Tables)

Table 1 Global Cell-Based Assays Market, By Product, 2011–2018 ($Million)
Table 2 Global Market, By Product, 2011–2018 ($Million)
Table 3 Market, By Geography, 2011–2018 ($Million)
Table 4 Global Consumables Market For Cell-Based Assays, By Product, 2011–2018 ($Million)
Table 5 Consumables Market, By Geography, 2011–2018 ($Million)
Table 6 Global Reagents & Assay Kits Market For Cell-Based Assays, By Type, 2011–2018 ($Million)
Table 7 Reagents & Assay Kits Market, By Geography, 2011–2018 ($Million)
Table 8 Cell Growth Assays Market, By Geography, 2011–2018 ($Million)
Table 9 Cell Death Assays Market, By Geography, 2011–2018 ($Million)
Table 10 Second Messenger Assays Market, By Geography, 2011–2018 ($Million)
Table 11 Reporter Gene Assays Market, By Geography, 2011–2018 ($Million)
Table 12 Other Cell-Based Assays Market, By Geography, 2011–2018 ($Million)
Table 13 Microplates Market For Cell-Based Assays, By Geography, 2011–2018 ($Million)
Table 14 Global Cell Lines Market For Cell-Based Assays, By Type, 2011–2018 ($Million)
Table 15 Cell Lines Market , By Geography, 2011–2018 ($Million)
Table 16 Other Consumables Market, By Geography, 2011–2018 ($Million)
Table 17 Global Instruments Market, By Type, 2011–2018 ($Million)
Table 18 Instruments Market, By Geography, 2011–2018 ($Million)
Table 19 Global Detection & Screening Instruments Market, By Product, 2011–2018 ($Million)
Table 20 Detection & Screening Instruments Market, By Geography, 2011–2018 ($Million)
Table 21 Microplate Readers Market, By Geography, 2011–2018 ($Million)
Table 22 Flow Cytometers Market , By Geography, 2011–2018 ($Million)
Table 23 Fluorescent Microscopes Market, By Geography, 2011–2018 ($Million)
Table 24 High Content Screening Instruments Market, By Geography, 2011–2018 ($Million)
Table 25 Label-Free Detection Instruments Market, By Geography, 2011–2018 ($Million)
Table 26 Other Detection & Screening Instruments For Cell-Based Assays Market, By Geography, 2011–2018 ($Million)
Table 27 Automation & Hts Instruments Market , By Geography, 2011–2018 ($Million)
Table 28 Software Market For Cell-Based Assays, By Geography, 2011–2018 ($Million)
Table 29 Services Market , By Geography, 2011–2018 ($Million)
Table 30 Global Market, By Application, 2011–2018 ($Million)
Table 31 Market For Basic Research, By Geography, 2011–2018 ($Million)
Table 32 Market For Drug Discovery, By Geography, 2011–2018 ($Million)
Table 33 Global Cell-Based Assays Market For Drug Discovery, By Type, 2011–2018 ($Million)
Table 34 Market For Target Identification & Validation, By Geography, 2011–2018 ($Million)
Table 35 Market For Lead Identification & Optimization, By Geography, 2011–2018 ($Million)
Table 36 Market For Adme Studies, By Geography, 2011–2018 ($Million)
Table 37 Market For Predictive Toxicology, By Geography, 2011–2018 ($Million)
Table 38 Market For Other Applications, By Geography, 2011–2018 ($Million)
Table 39 Global Market, By End User, 2011–2018 ($Million)
Table 40 Market For Pharmaceutical & Biotechnology Companies, By Geography, 2011–2018 ($Million)
Table 41 Market For Academic & Government Institutions, By Geography, 2011–2018 ($Million)
Table 42 Market For Contract Research Organizations, By Geography, 2011–2018 ($Million)
Table 43 Market For Other End Users, By Geography, 2011–2018 ($Million)
Table 44 Global Cell-Based Assays Market, By Geography, 2011–2018 ($Million)
Table 45 North America: Market, By Product, 2011–2018 ($Million)
Table 46 North America: Consumables Market For Cell-Based Assays, By Product, 2011-2018 ($Million)
Table 47 North America: Assay Kits & Reagents Market, By Type, 2011–2018 ($Million)
Table 48 North America: Instruments Market, By Type, 2011–2018 ($Million)
Table 49 North America: Detection & Screening Instruments Market, By Product, 2011–2018 ($Million)
Table 50 North America: Market, By Application, 2011–2018 ($Million)
Table 51 North America: Drug Discovery Market, By Type, 2011–2018 ($Million)
Table 52 North America: Market, By End User, 2011–2018 ($Million)
Table 53 Europe: Market, By Product, 2011–2018 ($Million)
Table 54 Europe: Consumables Market For Cell-Based Assays, By Product, 2011–2018 ($Million)
Table 55 Europe: Assay Kits & Reagents Market, By Type, 2011–2018 ($Million)
Table 56 Europe: Instruments Market For Cell-Based Assays, By Type, 2011–2018 ($Million)
Table 57 Europe: Detection & Screening Instruments Market , By Product, 2011–2018 ($Million)
Table 58 Europe: Market, By Application, 2011–2018 ($Million)
Table 59 Europe: Drug Discovery Market , By Type, 2011–2018 ($Million)
Table 60 Europe: Market, By End User, 2011–2018 ($Million)
Table 61 Asia: Market, By Product, 2011–2018 ($Million)
Table 62 Asia: Consumables Market For Cell-Based Assays, By Product, 2011–2018 ($Million)
Table 63 Asia: Assay Kits & Reagents Market, By Type, 2011–2018 ($Million)
Table 64 Asia: Instruments Market, By Type, 2011–2018 ($Million)
Table 65 Asia: Detection & Screening Instruments Market, By Product, 2011–2018 ($Million)
Table 66 Asia: Market, By Application, 2011–2018 ($Million)
Table 67 Asia: Drug Discovery Market, By Type, 2011–2018 ($Million)
Table 68 Asia: Market, By End User, 2011–2018 ($Million)
Table 69 ROW: Market, By Product, 2011–2018 ($Million)
Table 70 ROW: Consumables Market, By Product, 2011–2018 ($Million)
Table 71 ROW: Assay Kits & Reagents Market For Cell-Based Assays, By Type, 2011–2018 ($Million)
Table 72 ROW: Instruments Market, By Type, 2011–2018 ($Million)
Table 73 ROW: Detection & Screening Instruments Market, By Product, 2011–2018 ($Million)
Table 74 ROW: Cell-Based Assays Market, By Application, 2011–2018 ($Million)
Table 75 ROW: Market, By Type, 2011–2018 ($Million)
Table 76 ROW: Market, By End User, 2011–2018 ($Million)
Table 77 New Product Launches, 2012–2014
Table 78 Agreements, Partnerships & Collaborations, 2011–2013
Table 79 Acquistions, 2011–2014
Table 80 Other Developments, 2012–2013
Table 81 Becton, Dickinson and Company, By Segment, 2011–2013 ($Million)
Table 82 Danaher Corporation: Total Revenue, By Segment, 2011–2013 ($Million)
Table 83 Merck Kgaa: Total Revenue, 2011–2013 ($Million)
Table 84 General Electric: Total Revenue, By Segment, 2011–2013 ($Million)
Table 85 Life Technologies: Total Revenue, 2010–2012 ($Million)
Table 86 Life Technologies: Total Revenue, By Segment, 2010–2012 ($Million)
Table 87 Life Technologies: Total Revenue, By Geography, 2010–2012 ($Million)
Table 88 Perkinelmer: Total Revenue, By Segment, 2011–2013 ($Million)

List of Figures (20 Figures)

Figure 1 Forecast Model
Figure 2 Market Size Estimation Methodology & Triangulation
Figure 3 Data Triangulation Methodology
Figure 4 Global Market, By Application, 2013 & 2018
Figure 5 Market, By Geography, 2011–2018 ($Million)
Figure 6 Global Cell-Based Assays Market, 2013 ($Million)
Figure 7 Market Dynamics
Figure 8 Market Snapshot, 2013 ($Million)
Figure 9 Consumables & Instruments Market, 2013 ($Million)
Figure 10 Cell-Based Assays Market, Geographic Analysis, By Product, 2013 ($Million)
Figure 11 Opportunity Matrix: Global Market By Application, 2013
Figure 12 Global Market, By End User, 2013 Vs 2018 ($Million)
Figure 13 Market: Porter's Five Forces Analysis
Figure 14 Revenue Market Share Analysis, By Key Players, 2013
Figure 15 Global Market, By Product, 2013 ($Million)
Figure 16 Global Market, By Application, 2013 ($Million)
Figure 17 Cell-Based Assay Applications in Drug Discovery Stages
Figure 18 Global Market, By End User, 2011–2018 ($Million)
Figure 19 Cell-Based Assays Product Lifecycle, By Geography
Figure 20 Key Growth Strategies, 2011–2014

Cell-based assays are rapidly gaining importance in the field of drug discovery, predictive toxicology and basic research. The global market is estimated to be valued at $8,734 million in 2013 and will grow at a CAGR of 11.1% from 2013 to 2018.

Cell-based assays offer a sensitive and reliable technology that facilitates live cell studies for various research-based and commercial applications. These assays are emerging as a preferred tool when compared to other competing methods such as animal tests and biochemical assays. Cell based assays are more cost and time effective and have higher throughput when compared with conventional animal tests. Also, they produce accurate results and present wider range of applications than the biochemical assays. These are the major factors driving the growth of market.

The global cell-based assays market is segmented on the basis of products, applications, and end users. The products market is further subdivided into consumables (including reagents and assay kits, microplates and cell lines), instruments (detection and screening instruments such as microplate readers, flow cytometers, label-free detection instruments fluorescence microscopes, high content screening instruments and automation and high throughput screening instruments), software and cell based assay development services. Major types of cell based assays captured in the report include cell growth assays, cell death assays, second messenger assays and reporter gene assays.

Based on applications, the cell-based assays market is categorized into basic research, drug discovery, ADME, predictive toxicology and other applications. Drug discovery represents the largest share of amongst these applications. With rapid developments in fields such as cell biology, genomics, proteomics and bioinformatics, the number of potential drug candidates has risen significantly, and so have the drug discovery studies.

Based on end users, the market is segmented into pharmaceutical and biotechnology companies, academic and government institutes, and contract research organizations (CROs).

Based on geography, this market is further segmented into North America, Europe, Asia, and the Rest of the World (RoW). North America accounted for the largest market share of cell based assay in 2013, followed by Europe and Asia. However, the Asian market is expected to witness a healthy growth over the next five years due to the mushrooming CRO market in this region.

Government initiatives and public-private partnerships along with drying drug pipeline in pharmaceutical industry have led to increase in drug discovery activities; which is stimulating the market growth. Presently, the market is all set to witness trends such as label free detection, drug discovery outsourcing, 3D culture and stem cells. However, the major hindrances to the growth of the market are high-cost associated with detection technologies and intellectual property issues for assay kits.

The key players in the cell-based assays market include BD Biosciences (U.S.), Danaher Corporation (U.S.), DiscoveRx (U.S.), EMD Millipore (Germany), GE Healthcare (U.K), Life Technologies Corporation (U.S.), PerkinElmer (U.S.), Corporation (U.S.) and Promega (U.S.).

Global Cell Based Assay Market Size Snapshot, 2013 ($Million)

Cell-based Assays Market

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441
UK : 44-800-368-9399

Search reports